Arnd joined VI Partners in August 2001 as a partner focusing on early-stage life science investments.
Before that he built a team dedicated to venture capital transactions in the life science and health care industry for KPMG Corporate Finance (98-01). He gained his entrepreneurial experience in several medical device and e-health start-ups where he held various management positions (91-98). As an MD he started his professional career in a university hospital and in medical research (87-91).
In addition to being an MD Arnd also holds an MBA from Kellogg Graduate Business School, USA, and WHU Koblenz, Germany, as well as a Postgraduate Degree in Computer Sciences from TU Munich, Germany. He is fluent in German, English and French.
Arnd carries the prime responsibility for the following portfolio companies: Altoida, Cell Medica, Inositec, JenaValve, Kuros and Ventaleon.